Myotonic dystrophy types 1 and 2.

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Myotonic dystrophies (DM) are inherited neuromuscular disorders characterized by myotonia and progressive muscle degeneration.
• Two main types, DM1 and DM2, result from expanded DNA repeat sequences in untranslated regions.

Purpose of the Study:

• To elucidate the genetic basis and pathogenic mechanisms of myotonic dystrophies types 1 and 2.
• To compare the distinct features and molecular underpinnings of DM1 and DM2.
• To explore emerging therapeutic strategies based on disease mechanisms.

Main Methods:

• Analysis of expanded short tandem repeat DNA sequences (CTG)n and (CCTG)n.
• Investigation of repeat-size instability patterns in DM1 and DM2.
• Examination of RNA-mediated pathogenic mechanisms involving MBNL protein sequestration and altered gene splicing.

Main Results:

• DM1 and DM2 exhibit different repeat-size instability patterns.
• While phenotypes are similar, key differences exist in disease severity, affected muscles, fiber types, and multisystemic involvement.
• Evidence suggests mutant RNA sequestration of MBNL proteins leads to misregulated splicing.

Conclusions:

• DM1 and DM2 pathogenesis involves expanded repeat RNA transcripts sequestering MBNL proteins, causing aberrant splicing.
• Additional mechanisms like chromatin changes and gene dysregulation are implicated.
• Current treatments are supportive, but future therapies targeting pathogenic pathways are promising.